A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome. - Contacts and Locations

A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome.

This study has been completed.

Study NCT00527917. Last updated on November 6, 2008. Information provided by Watson Pharmaceuticals

Please refer to this study by its ClinicalTrials.gov identifier: NCT00527917

Locations


Canada, British Columbia

	Surrey, British Columbia, Canada

	Vancouver, British Columbia, Canada

	Victoria, British Columbia, Canada

Canada, Nova Scotia

	Kentville, Nova Scotia, Canada

Canada, Ontario

	Toronto, Ontario, Canada

	Kitchener, Ontario, Canada

	Barrie, Ontario, Canada

	Guelph, Ontario, Canada

	Brantford, Ontario, Canada

	Newmarket, Ontario, Canada

	Kingston, Ontario, Canada

	Thunder Bay, Ontario, Canada

	North Bay, Ontario, Canada

Sponsors and Collaborators

Watson Pharmaceuticals

Investigators


Study Director:	Keshava Kumar, PhD	Watson Pharmaceuticals